Novel inhibitors of human histone deacetylases: Design, synthesis and bioactivity of 3-alkenoylcoumarines

Carole Seidel, Michael Schnekenburger, Clemens Zwergel, François Gaascht, Antonello Mai, Mario Dicato, Gilbert Kirsch, Sergio Valente, Marc Diederich

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Histone deacetylases (HDACs) are well-established, promising targets for anticancer therapy due to their critical role in cancer development. Accordingly, an increasing number of HDAC inhibitors displaying cytotoxic effects against cancer cells have been reported. Among them, a large panel of chemical structures was described including coumarin-containing molecules. In this study, we described synthesis and biological activity of new coumarin-based derivatives as HDAC inhibitors. Among eight derivatives, three compounds showed HDAC inhibitory activities and antitumor activities against leukemia cell lines without affecting the viability of peripheral blood mononuclear cells from healthy donors. ?? 2014 Elsevier Ltd. All rights reserved.
Original languageEnglish (US)
Pages (from-to)3797-3801
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume24
Issue number16
DOIs
StatePublished - Aug 15 2014

Keywords

  • Anti-proliferative activity
  • Cancer
  • Chalcone
  • Coumarin
  • Histone deacetylase inhibitors

Fingerprint Dive into the research topics of 'Novel inhibitors of human histone deacetylases: Design, synthesis and bioactivity of 3-alkenoylcoumarines'. Together they form a unique fingerprint.

Cite this